Yahoo Finance Berry Global Group, Inc. (NYSE:BERY) Q2 2024 Earnings Call Transcript
Berry Global Group, Inc. (NYSE:BERY) Q2 2024 Earnings Call Transcript May 9, 2024
Berry Global Group, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $1.9. Berry Global Group, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good day, and thank you for standing by. Welcome to the Second Quarter 2024 Berry Global Group Earnings Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Dustin Stilwell, Investor Relations. Please go ahead.
Dustin Stilwell: Thank you, operator, and thank you to everyone for joining Berry's second fiscal quarter 2024 earnings call. Joining me this morning, I have Berry's Chief Executive Officer, Kevin Kwilinski; Berry's Chief Financial Officer, Mark Miles. Following our comments today, we will have a question-and-answer session. In order to allow everyone the opportunity to participate, we do ask that you limit yourself to one question with a brief follow-up, and then fall back into the queue for any additional questions. A few things to note before handing the call over. On our website at berryglobal.com, you can find today's press release and earnings call presentation under our Investor Relations section. As referenced on Slide 2 and Slide 3, during this call, we will be discussing certain non-GAAP financial measures.
These measures are reconciled to the most directly comparable GAAP financial measures in our earnings press release and presentation, which were made public earlier this morning. Additionally, we will make forward-looking statements that are subject to risks and uncertainties. Actual results or outcomes may differ materially from those that may be expressed or implied in our forward-looking statements. Some factors that could cause the results or outcomes to differ are in the company's latest 10-K, our other SEC filings, and our news releases. I will now turn the call over to Berry's CEO, Kevin Kwilinski.
Kevin Kwilinski: Thank you, Dustin, and thank you to everyone for joining us today to discuss Berry's second quarter results for fiscal 2024. The second quarter came in consistent with our expectations. Our proactive measures around repositioning our portfolio to higher growth markets and reducing our cost structure have allowed us to outperform in a weaker than normal macro demand environment. We're excited to share that our team has identified additional opportunities to enhance our competitive position. As a result, we've expanded our cost savings program by an extra $25 million bringing the total to $165 million. We're on track to achieve these savings by the end of fiscal year 2025. Our confidence is bolstered by steadily improved volumes throughout the year with an accelerating improvement in April.
As a result, we reaffirm our fiscal 2024 guidance expecting low single digit volume growth in the second half of the year aligned with our long-term targets. Our outlook for a robust second half of the year remains unchanged and we're committed to achieving year end leverage of 3.5 times or lower. With six months in the chair, having visited dozens of locations and having talked to numerous customers and suppliers, I'm struck by our fantastic opportunity for growth and operational excellence. We are focused on three key efforts. One, optimizing our portfolio to accelerate both growth and deleveraging. Two implementation of our lean transformation and three, accelerating growth by improving our commercial excellence approach. With respect to portfolio optimization, we are making substantial progress.
We completed two additional divestitures in the quarter and we have line of sight to much more. Looking forward, we believe cash proceeds could exceed $2 billion from strategic divestitures within the next year. This includes $1 billion from the already announced spin off merger and another $1 billion from future portfolio optimization opportunities. Not only will these divestitures accelerate deleveraging, they will push us toward our goal of increasing our consumer products focus from over 70% to over 80% of volume. In April, we announced the achievement of a regulatory milestone in the proposed transaction involving the combination of a majority of our Health, Hygiene and Specialty segment to include its global nonwovens and films business with Glatfelter.
With the expiration of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. As previously announced in February, Berry and Glatfelter entered into a definitive agreement under which Berry will spin off and merge its HHNF business with Glatfelter in a reverse Morris Trust transaction. The transaction will create a leading publicly traded company in the specialty materials industry. The transaction is still expected to close in the second half of calendar 2024 and is subject to approval by Glatfelter shareholders and completion of customary closing conditions. Both Glatfelter and Berry HHNF performed in line with our transaction thesis during the quarter validating our belief that the business cycle has bottomed out for each of these companies.
As we prepare for integration, we remain optimistic about substantial upside potential in our base synergy case. Turning to our lean transformation. During the quarter, we made substantial progress in accelerating our continuous improvement focus. With a customer first approach, we reengineered our quality and service management process to be directly connected to a new NPS process. During the quarter, we implemented our first cycle of NPS and collected valuable data to confirm our strength and to focus us on areas of opportunity that will lean to growth. Our operational leadership from North America and Europe recently visited Toyota facilities to observe and learn firsthand about their world class lean production system. We also hired an experienced lean transformation leader who started this week and reports directly to me.
This leader has a successful track record in lean practices at companies like Honda, Danaher and Honeywell. Additionally, we're actively developing a pipeline of opportunities to enhance efficiency by increasing overall equipment effectiveness and improving first pass yield. We're excited to incorporate these initiatives into our 2025 budget planning. Finally, I want to discuss our focus on commercial excellence. Slide 6 speaks to the substantial levers that empower us to achieve consistent, dependable and sustainable organic growth. Berry's inherent scale advantages drive both cost leadership and innovation capabilities, instilling confidence that we will consistently deliver robust earnings growth from our stable portfolio of businesses, but these levers need to be executed in the context of a world class commercial excellence process and in this aspect, Berry will become much stronger in the months ahead.
With company wide world class commercial excellence in mind, during the quarter, we created a beachhead in our core North American rigid consumer packaging business. We have substantial opportunity to win in this space and we are investing in creating a world class commercial excellence model and accelerating innovation and technology to increase our strategic product differentiation. To drive commercial excellence, we launched an effort with a top tier consulting organization to bring best in class process and tools to our pipeline identification, management and delivery. Following full successful implementation, we will take this new commercial excellence model and replicate it across the balance of our businesses. With respect to innovation and technology, we completed the strategic acquisition of F&S Tool to give us access and control of unique tooling intellectual property, allowing for more costs and capital efficient sustainable alternatives to traditional products.
F&S brings an incredible culture of entrepreneurial innovation, which will serve to accelerate our organic growth delivery, while bringing additional scale to our already substantial growing and important tooling and automation capability. Combining superior product and service differentiation enabled by our lean transformation with the strongest innovation engine in the industry and executing in the framework of a world class commercial excellence engine is allowing Berry to win faster in our markets and achieve our growth objectives in a sustainable way. Now, I will turn the call over to Mark, who will review Berry's financial results. Mark?
Mark Miles: Thank you, Kevin. Turning now to financial results highlights on Slide 8. As Kevin mentioned, our quarterly results for both revenue and earnings were in line with our expectations. I am pleased to report that sequentially volumes improved for each of our four operating segments. Our global teams have continued to optimize our manufacturing footprint without disruption to our customers and improve our product mix across our businesses. We have made significant progress in consolidating our higher cost assets and as volumes recover, we expect an incremental benefit to earnings on more efficient assets. Our focus on continuous improvement led to another increase in our cost reduction program of $25million which we plan on fully realizing in fiscal 2025.
We still expect to realize $55 million in fiscal 2024 and now $35 million in fiscal 2025, which excludes incremental benefits we expect from the lean transformation initiative. These strategic actions and focus are helping to counter the challenges of soft market demand caused by inflation. For the quarter, adjusted earnings per share was similar to the prior comparable year coming in at $1.95 per share, while operating EBITDA was down 5%, primarily due to softer volumes and the impact from the timing of passing through polymer costs with both of these items expected to change from year-over-year headwinds in the first half to tailwinds in the second half. I would like to refer everyone to Slide 9 for our quarterly performance by each of our four operating segments.
The segment review will focus on the year over year changes for fiscal Q2. Starting with our Consumer Packaging International division, revenue was down 8%, primarily from the past through polymer costs. Both our Consumer and Industrial markets improved by over 2% compared to the year over year changes in Q1. Both markets across Europe saw incremental improvements, modestly ahead of our expectations and we continue to execute our strategy to improve product mix to higher value products. EBITDA was down 4%, which was modestly higher than the 1% decrease in volumes, primarily driven by a modest negative impact from the timing of polymer pass through. In the second half of 2024, we expect to benefit from our cost reduction efforts along with the decrease in energy costs in certain regions of Europe.
We also continue to invest and expect improved product mix by utilizing our sustainability leadership and increasing our presence in healthcare packaging, pharmaceutical devices and dispensing systems. Next on Slide 10, revenue in our Consumer Packaging North America division was down 4% resulting from softer overall customer demand of 3% from inflation and lower selling prices due to the pass through of resin costs. Overall volume trajectory improved led by our food, beverage, personal care, home care and industrial markets, while foodservice markets saw modest decline given strong comparisons in that business. We continue to see substrate conversions to plastic from paper, foam, glass and metal, as we continue to incorporate more circular material, deliver a more sustainable solution and provide end consumers with a better experience.
EBITDA was down 11% compared to the prior year quarter, primarily driven by resin pass-through timing and softer market demand, partially offset by our cost reduction efforts and our focus on higher value products such as closures, foodservice and highly decorated containers. On Slide 11, revenue in our Flexibles division was down 9%, primarily due to lower selling prices in the pass through of lower resin costs and volume softness primarily in our North American transportation and shrink film markets offset by growth in our European film products. Overall, volumes improved sequentially over Q1 and are impacted by our focused effort to mix up in certain categories such as consumer and transportation protection products. EBITDA for the quarter was flat versus the prior year quarter as we saw improved product mix in the higher value product categories offset by softer customer demand in our North American markets.
On Slide 12, revenue in our Health, Hygiene and Specialties division was down 6%, primarily due to lower resin prices and modest decline in hygiene and certain specialty products, partially offset by improved demand in our surgical suite and hard surface disinfectant wipe markets. We are encouraged as overall volumes have improved sequentially over the past three quarters. EBITDA was essentially flat versus the prior year quarter, driven by structural cost reduction initiatives, offset by timing of resin pass-through and product mix. Our consistent cash flows have granted us the flexibility to provide robust returns to our shareholders, a key strength and core value of our company. This financial stability allows us to invest in our businesses, foster growth, enhance efficiency and simultaneously return capital to our shareholders.
As illustrated on Slide 13, our unchanged capital allocation strategy is return based and encompasses continued investment in growth markets, strategic portfolio management, debt repayment, share repurchases and a growing quarterly cash dividend. As part of our ongoing efforts to improve our product portfolio, we completed two divestitures in the quarter. We divested a European Industrial Vehicles business and a U.K. based Home and Garden business, which were both historically reported inside our Consumer Packaging International segment. Revenue for these businesses totaled approximately $150 million with profit margins well below the company average. Since the RPC acquisition in 2019, we have completed 10 divestitures as we have continued our strategic portfolio management.
As Kevin mentioned, we expect to generate proceeds of over $2 billion within the next year, including our previously announced proposed spin merger transaction with Glatfelter as we continue the optimization of our portfolio. These divestitures are in direct alignment with our long-term strategy of simplifying the portfolio and enhancing the stability of earnings and improving long-term growth. Leveraging our strong and dependable cash flows, we have continued to strengthen our strong balance sheet, focusing on driving long-term value for our shareholders and anticipate being within our targeted leverage range by the end of fiscal 2024. We believe we are well positioned for continued value creation. Our strong cash flows have allowed us the flexibility to drive robust returns for our shareholders.
As demonstrated on Slide 14, Berry has reduced net debt by more than $3 billion since mid-2019, along with more than $1.5 billion returned to shareholders through both share repurchases and dividends in fiscal 2022 and 2023. In fiscal 2024, we anticipate a balanced capital allocation utilizing our free cash flow for debt repayment, share repurchases and regular quarterly dividends. By the end of fiscal 2024, we expect that we will have returned an impressive $5.4 billion of cumulative net debt reduction and capital returns since fiscal 2020. As you can see on Slide 15, Berry's history of driving top tier results across various key financial metrics such as revenue, earnings and free cash flow highlights our consistent growth from the solid execution of our strategies.
We remain committed to enhancing long-term value for all stakeholders by maintaining a stable and dependable portfolio. This consistency has been validated through many different economic cycles and since our last significant acquisition of RPC in 2019, we have delivered free cash flow every year between $850 million and $1 billion. Additionally, from an earnings perspective, our annual adjusted EPS CAGR of over 20% from 2015 to 2023 with the leading position amongst our peer set and is well above the peer adjusted EPS CAGR of 8%. This concludes my financial review, and now I will turn it back to Kevin.
Kevin Kwilinski: Thank you, Mark. Our fiscal 2024 guidance and assumptions outlined on Slide 16 reflect a solid first half performance aligning with our expectations. Today, we are reaffirming our full year guidance for adjusted earnings per share ranging from $7.35 to $7.85. We expect earnings to strengthen in the second half of fiscal 2024, both sequentially and on a comparable basis to fiscal 2023. This is driven by resin pass-through timing, benefits from cost reduction efforts and capital project timing. We continue to expect given our strong April volumes, the easing of inflation and easier comparisons year over year, reported volumes to improve as we progress through the second half of fiscal 2024. Also, as Mark stated, we anticipate incremental benefits to earnings on more efficient assets as volumes recover during the year.
We continue to expect free cash flow to be in the range of $800 million to $900 million assuming cash from operation of $1.350 billion to $1,450 billion, less capital expenditures of $550 million. Furthermore, and in line with our focus on driving long-term shareholder value, in fiscal We continue to believe our shares are undervalued and our repurchases reflect our confidence in the outlook for our business and long-term strategy. As you can see on Slide 17, Berry has consistently met or exceeded its targets over the past several years and we expect to continue doing so in the future. Our long-term targets emphasize the consistency and dependability of our model with EBITDA growth of 4% to 6%, adjusted EPS growth of 7% to 12% and total shareholder returns of 10% to 15%.
Additionally, our dividend is expected to grow annually and we aim to achieve our recently lowered long term leverage target by the end of fiscal 2024. In summary, our strategic priorities remain steadfast: optimize the portfolio, implement lean transformation and accelerate growth with world class commercial excellence. With line of sight to achieving low-three's leverage in the next 12 to 18 months, lean transformation pipeline allowing for 2% to 3% conversion cost reduction per year and an ability to organically grow 2% to 3% per year, we expect to deliver peer leading performance. Our optimism for the remainder of fiscal 2024 stems from several factors including the continued easing of inflation and a return to more normalized levels of customer promotional activity.
We reaffirm our earnings and cash flow guidance confident in our visibility towards solid earnings growth in the second half. Finally, we have executed on areas to improve our valuation multiple. We have improved our strong balance sheet, lowered our targeted leverage range and returned substantial cash to shareholders. Additionally, as we continue to demonstrate sales volume at or above peer average and execute our strategies, we believe we will continue to close the valuation gap to peer group presenting an attractive investment opportunity. Thank you for your time and interest in Berry. And with that, Mark and I are happy to address any questions which you may have. Operator?
See also
10 Weakest Militaries in Europe and
25 Countries with the Most Cigarette Smokers per Capita.
To continue reading the Q&A session, please click here.
